Nathaniel Herzfeld

Array ( [id] => 9375887 [patent_doc_number] => 08680152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain' [patent_app_type] => utility [patent_app_number] => 13/462587 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307238 [patent_doc_number] => 20140045912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'COMPOSITION AND METHOD FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 14/113650 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307238 [patent_doc_number] => 20140045912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'COMPOSITION AND METHOD FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 14/113650 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909415 [patent_doc_number] => 08481480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-09 [patent_title] => 'Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol' [patent_app_type] => utility [patent_app_number] => 13/460284 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5037 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909415 [patent_doc_number] => 08481480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-09 [patent_title] => 'Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol' [patent_app_type] => utility [patent_app_number] => 13/460284 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5037 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503097 [patent_doc_number] => 20120302505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/452132 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 60438 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9462813 [patent_doc_number] => 20140127240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'Novel Binder-Drug Conjugates (ADCs) and Use of Same' [patent_app_type] => utility [patent_app_number] => 14/113070 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 149017 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902235 [patent_doc_number] => 20150057434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'METHODS OF PURIFYING HYDROPHOBIN' [patent_app_type] => utility [patent_app_number] => 14/112215 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10793 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465627 [patent_doc_number] => 20120270796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Suspension Type Topical Formulations Comprising Cyclic Depsipeptide' [patent_app_type] => utility [patent_app_number] => 13/445202 [patent_app_country] => US [patent_app_date] => 2012-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5863 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477744 [patent_doc_number] => 20120277150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'NOVEL 3-HYDROXYISOTHIAZOLE 1-OXIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/444595 [patent_app_country] => US [patent_app_date] => 2012-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91492 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13444595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11479408 [patent_doc_number] => 09585930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Therapeutic agent for emphysema and COPD' [patent_app_type] => utility [patent_app_number] => 14/004781 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 38740 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896700 [patent_doc_number] => 08476221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Methods and compositions for the treatment of metabolic disorders' [patent_app_type] => utility [patent_app_number] => 13/423491 [patent_app_country] => US [patent_app_date] => 2012-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17932 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382206 [patent_doc_number] => 20120225827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'SILICONE-BASED OPHTHALMIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/410828 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13410828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846250 [patent_doc_number] => 08455431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Inhibitors of the trypsin-like site of the proteasome and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/399189 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 11 [patent_no_of_words] => 22293 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371141 [patent_doc_number] => 20120220531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY' [patent_app_type] => utility [patent_app_number] => 13/366144 [patent_app_country] => US [patent_app_date] => 2012-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8050 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13366144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253239 [patent_doc_number] => 20120157563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/363650 [patent_app_country] => US [patent_app_date] => 2012-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8123 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157563.pdf [firstpage_image] =>[orig_patent_app_number] => 13363650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307087 [patent_doc_number] => 20140045761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'WOUND PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/982913 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19892 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347833 [patent_doc_number] => 20120208758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'COMPOSITION FOR THE ATTACHMENT OF IMPLANTS TO COLLAGEN OR OTHER COMPONENTS OF BIOLOGICAL TISSUE' [patent_app_type] => utility [patent_app_number] => 13/353952 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8238 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13353952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10082481 [patent_doc_number] => 09119811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Fluorocarbon-linked peptide formulation' [patent_app_type] => utility [patent_app_number] => 13/977265 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 16075 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844243 [patent_doc_number] => 08946159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment' [patent_app_type] => utility [patent_app_number] => 13/374369 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11429 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13374369 [rel_patent_id] =>[rel_patent_doc_number] =>)